Tripelennamine hydrochloride, also known as Pyribenzamine hydrochloride, is a first-generation H1 antihistamine. It is characterized by relatively low sedative effects but a notable incidence of gastrointestinal side effects. This compound is utilized in pharmacological research to study histamine receptor antagonism in both in vitro binding assays and in vivo models of allergic response.
